American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry159 (4 Suppl.): 1-50
2.
Angst J (1978) The course of affective disorders: II. Typology of bipolar manic-depressive illness. Archiv fur Psychiatrie und Nervenkrankheiten226: 65-73
3.
Baillarger J (1854) De la folie à double-forme. Ann Med Psychol (Paris)6: 367-391
4.
Colom F, Lam D (2005) Psychoeducation: improving outcomes in bipolar disorder. Eur Psychiatry20(5-6): 359-364
5.
Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea J M, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J (2003) A randomized trial on the efficacy of group psychoeducation in the
prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry60(4): 402-407
6.
Das Gupta R, Guest J F (2002) Annual cost of bipolar disorder to UK societyBr J Psychiatry180: 227-233
7.
Eberhard-Gran M, Eskild A, Opjordsmoen S (2005) Treating mood disorders during pregnancy: safety considerations. Drug Saf28(8): 695-706
8.
Falret J P (1854) Mémoire sur la folie circulaire. Bull l’Acad Méd19: 384-415
9.
Goodwin G M, Young A H (2003) The British Association for Psychopharmacology guidelines for treatment of
bipolar disorder: a summary. J Psychopharmacol17 (4 Suppl.): 3-6
10.
Goodwin G M, Bowden C L, Calabrese J R, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine
and lithium maintenance in bipolar I disorder. J Clin Psychiatry65: 432-441
11.
Hartigan G P (1963) The use of lithium salts in affective disorders. BJPsych109: 810-814
12.
Johnson R E, McFarland B H (1996) Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry153: 993-1000
13.
Kraepelin E (1896) Psychiatrie. Reprinted (1971) in part as
Dementia Praecox and Paraphrenia (R M Barclay, Trans. 8th ed). Robert E Krieger, Huntingdon, NY
14.
Lam D H, Watkins E R, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P (2003) A randomized controlled study of cognitive therapy for relapse prevention
for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry60(2): 145-152
15.
Leonard K (1957) Pathogenesis of manic-depressive disease. Nervenarzt28(6): 271-272
16.
Morriss R, Mohammed F A (2005) Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol19 (6 Suppl.) 94-101
17.
Muller-Oerlinghausen B, Berghofer A, Bauer M (2002) Bipolar disorder. Lancet359(9302): 241-247
18.
Muzina D J, Calabrese J R (2005) Maintenance therapies in bipolar disorder: focus on randomized controlled trialsAust N Z J Psychiatry39(8): 652-661
19.
Perry A, Tarrier N, Morriss R, McCarthy E, Limb K (1999) Randomised controlled trial of efficacy of teaching patients with bipolar
disorder to identify early symptoms of relapse and obtain treatment. BMJ318(7177): 149-153
Scott J (2002) Cognitive therapy in bipolar disorderExpert Rev Neurother2(4): 573-581
22.
Scott J, Colom F (2005) Psychological treatments for bipolar disorders. Psychiatric Clinics of North America28: 371-384
23.
Suppes T, Dennehy E B, Hirschfeld R M (2005) Texas Consensus Conference Panel on Medication Treatment of Bipolar
Disorder. The Texas implementation of medication algorithms: update to the
algorithms for treatment of bipolar I disorder. J Clin Psychiatry66(7): 870-886
24.
Vajda F J, Eadie M J (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand112(3): 137-143
25.
Vieta E (2005) Improving treatment adherence in bipolar disorder through psychoeducationJ Clin Psychiatry1 (66 Suppl.): 24-29
26.
Yatham L N, Kennedy S H, O’Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young L T, Ravindran A, Schaffer A, Connolly M, Gorman C P (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for
the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord7 (Suppl. 3): 5-69
